Imricor Medical Systems Inc - Asset Resilience Ratio
Imricor Medical Systems Inc (IMR) has an Asset Resilience Ratio of 46.50% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IMR working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how Imricor Medical Systems Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Imricor Medical Systems Inc total assets.
Liquid Assets Composition Over Time
This chart breaks down Imricor Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Imricor Medical Systems Inc to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$21.29 Million | 46.5% |
| Total Liquid Assets | AU$21.29 Million | 46.50% |
Asset Resilience Insights
- Very High Liquidity: Imricor Medical Systems Inc maintains exceptional liquid asset reserves at 46.50% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Imricor Medical Systems Inc Industry Peers by Asset Resilience Ratio
Compare Imricor Medical Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Imricor Medical Systems Inc (2023–2025)
The table below shows the annual Asset Resilience Ratio data for Imricor Medical Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 46.50% | AU$21.29 Million ≈ $15.07 Million |
AU$45.79 Million ≈ $32.40 Million |
+51.16pp |
| 2023-12-31 | -4.66% | AU$-387.09K ≈ $-273.89K |
AU$8.31 Million ≈ $5.88 Million |
-- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more